These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7699)

  • 1. [Dynamic observations of tolerance to physical exercise in patients with ischemic heart disease during drug therapy].
    Lupanov VP
    Kardiologiia; 1975 Sep; 15(9):68-73. PubMed ID: 7699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Certain problems of treatment of ischemic heart disease].
    Zamotaev IP; Lozinskiĭ LG; Venediktova MG; Sandomirskiĭ BL
    Kardiologiia; 1975 Jul; 15(7):16-24. PubMed ID: 1567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possibilities of differential treatment of the chronic form of ischemic heart disease].
    Miasnikov LA; Metelitsa VI
    Ter Arkh; 1973; 45(6):8-21. PubMed ID: 4148246
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of tobanum on various functions of the heart in patients with ischemic heart disease and prospects for its clinical application].
    Gambashidze NB; Kobaladze SG; Burdiashvili BSh; Kikodze NL; Mamaladze GT
    Kardiologiia; 1985 Sep; 25(9):77-9. PubMed ID: 2867245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular drugs: effects on exercise testing and exercise training of the coronary patient.
    Wenger NK
    Cardiovasc Clin; 1985; 15(2):133-43. PubMed ID: 2868791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Various aspects of drug therapy of chronic forms of ischemic heart disease].
    Kipshidze NN; Chumburidze VB
    Kardiologiia; 1985 Sep; 25(9):37-40. PubMed ID: 2867241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta-receptor blockers in ischemic heart disease: the pathophysiological and clinical aspects].
    Urbaszek W; Modersohn D
    Z Arztl Fortbild (Jena); 1979 Feb; 73(3):101-6. PubMed ID: 34938
    [No Abstract]   [Full Text] [Related]  

  • 8. [Coronary reserve and differentiated therapy of its disorder].
    Kukes VG; Kniazev MD; Vorobkov AI; Semenov VN; Abugov AM
    Kardiologiia; 1975 Jun; 15(6):52-7. PubMed ID: 241874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of anabolic steroids and adrenergic beta receptor blockaders on the indicators of rheogram of the aorta and lungs in patients with ischemic heart disease].
    Sharlaĭ IR
    Vrach Delo; 1974 Aug; 0(8):15-7. PubMed ID: 4153197
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of long-term anti-arrhythmia treatment on the status of ischemic heart disease patients].
    Markov KV; Sapozhnikova AA
    Kardiologiia; 1986 Jun; 26(6):51-3. PubMed ID: 2876122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of anti-anginal therapy on the functional state of the myocardium in patients with chronic ischemic heart disease].
    Adamian KG; Asatrian MA; Oganesian LS; Grigorian NKh; Akopian BR
    Kardiologiia; 1985 Sep; 25(9):52-5. PubMed ID: 3935848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Fendilin on the exercise test in patients with coronary disease].
    Spiel R; Enenkel W
    Wien Med Wochenschr; 1976 Mar; 126(13-14):186-9. PubMed ID: 10680
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intervention in ischemic heart disease and myocardial infarction. 3. Medical intervention].
    Pedersen A
    Ugeskr Laeger; 1982 Jul; 144(29):2156-64. PubMed ID: 6128809
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy and tolerance of trimetazidine, a metabolic antianginal, in combination with a hemodynamic antianginal in stable exertion angina. TRIMPOL I, a multicenter study].
    Szwed H; Pachocki R; Domzal-Bochenska M; Szymczak K; Szydlowski Z; Paradowski A; Gajos G; Kaluza G; Kulon I; Wator-Brzezińska A; Elikowski W; Kuźniak M
    Presse Med; 2000 Mar; 29(10):533-8. PubMed ID: 10761517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Importance of obsidan for increasing exercise tolerance in elderly patients with ischemic heart disease].
    Kotko DN; Fed'ko GP; Iaroshenko IuT
    Ter Arkh; 1980; 52(8):22-5. PubMed ID: 6114575
    [No Abstract]   [Full Text] [Related]  

  • 16. [Correction of hemodynamic and metabolic disorders in patients with ischemic heart disease].
    Bondarenko IP
    Vrach Delo; 1988 Mar; (3):31-4. PubMed ID: 3394292
    [No Abstract]   [Full Text] [Related]  

  • 17. [Objective evaluation of the therapeutic activity of iproveratril].
    Cherchi A; Raffo M; Bina M; Fonzo R; Maxia G; Esu MP
    Minerva Cardioangiol; 1971 Mar; 19(3):123-32. PubMed ID: 5553461
    [No Abstract]   [Full Text] [Related]  

  • 18. [Beta-adrenoblockaders and calcium antagonists in the treatment of patients with ischemic heart disease combined with hypertension].
    Andrushchenko EV; Chmir VP; Krasovskaia EA; Malanchuk TA; Polishchuk II; Iashchenko OB
    Vrach Delo; 1990 Nov; (11):35-8. PubMed ID: 1983050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a one-time dose of prolonged-action beta-adrenoblockaders and nitrates on the tolerance of physical loads in ischemic heart disease].
    Ermilov LP; Kuleshova EV; Treshkur TV; Andreeva IV
    Klin Med (Mosk); 1980 Apr; 58(4):77-81. PubMed ID: 6103973
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of beta-adrenergic blocking agents and anabolic steroids in ischemic heart disease].
    Girina NI
    Vrach Delo; 1979 Dec; (12):48-50. PubMed ID: 43030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.